Back
Ascendis Pharma AS Stock Price Chart

Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
41
ASND
Ascendis Pharma AS
Last Price:
$154.97
Seasonality Move:
-2.92%
7 Day Trial
ALL ACCESS PASS
$
7

Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is moderately bullish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.
Ascendis Pharma AS Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 163.15 | Sell |
20-day SMA: | 157.07 | Buy |
50-day SMA: | 143.05 | Buy |
200-day SMA: | 135.67 | Buy |
8-day EMA: | 160.7 | Sell |
20-day EMA: | 156.77 | Buy |
50-day EMA: | 147.95 | Buy |
200-day EMA: | 136.84 | Buy |
Ascendis Pharma AS Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.21 | Buy |
Relative Strength Index (14 RSI): | 53.8 | Buy |
Chaikin Money Flow: | -164422 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (149.84 - 162.8) | Buy |
Bollinger Bands (100): | (124.58 - 150.08) | Buy |
Ascendis Pharma AS Technical Analysis
Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Ascendis Pharma AS Stock
Is Ascendis Pharma AS Stock a Buy?
-
Ascendis Pharma AS share price is 157.94 while ASND 8-day simple moving average is 163.15, which is a Sell signal.
-
The stock price of ASND is 157.94 while Ascendis Pharma AS 20-day SMA is 157.07, which makes it a Buy.
-
Ascendis Pharma AS 50-day simple moving average is 143.05 while ASND share price is 157.94, making it a Buy technically.
-
ASND stock price is 157.94 and Ascendis Pharma AS 200-day simple moving average is 135.67, creating a Buy signal.
ASND Technical Analysis vs Fundamental Analysis
Sell
41
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy or a Sell?
-
Ascendis Pharma AS stock is rated a SellThe current Ascendis Pharma AS [ASND] share price is $157.94. The Score for ASND is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Ascendis Pharma AS Stock Info
Market Cap:
9.5B
Price in USD:
157.94
Share Volume:
265K
Ascendis Pharma AS 52-Week Range
52-Week High:
169.37
52-Week Low:
111.09
Sell
41
Ascendis Pharma AS (ASND)
is a Sell
Ascendis Pharma AS Share Price Forecast
-
What is the Ascendis Pharma AS stock price today?The Ascendis Pharma AS stock price is 157.94 USD today.
-
Will ASND stock go up or go down?Ascendis Pharma AS> share price is forecast to RISE/FALL based on technical indicators
-
Is Ascendis Pharma AS overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ascendis Pharma AS is overvalued.
Is Ascendis Pharma AS Stock a Buy?
-
Ascendis Pharma AS share price is 157.94 while ASND 8-day exponential moving average is 160.70, which is a Sell signal.
-
The stock price of ASND is 157.94 while Ascendis Pharma AS 20-day EMA is 156.77, which makes it a Buy.
-
Ascendis Pharma AS 50-day exponential moving average is 147.95 while ASND share price is 157.94, making it a Buy technically.
-
ASND stock price is 157.94 and Ascendis Pharma AS 200-day simple moving average is 136.84, creating a Buy signal.
Fundamental Analysis of Ascendis Pharma AS
Is Ascendis Pharma AS a good investment?
-
Analysts estimate an earnings increase this quarter of $0.81 per share, an increase next quarter of $0.04 per share, an increase this year of $3.20 per share, and an increase next year of $5.33 per share.
Technical Analysis of Ascendis Pharma AS
Should I short Ascendis Pharma AS stock?
-
ASND Moving Average Covergence Divergence (MACD) indicator is 5.21, suggesting Ascendis Pharma AS is a Buy
-
Ascendis Pharma AS Relative Strength Index (RSI) is 53.8, which suggest Ascendis Pharma AS is overbought
-
The Bollinger Bands (25) for Ascendis Pharma AS is (149.84 - 162.8), which suggest Ascendis Pharma AS is a Buy
-
The Bollinger Bands (100) for Ascendis Pharma AS is (124.58 - 150.08), which suggest Ascendis Pharma AS is a Buy
* Ascendis Pharma AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.